IL51574A - Process for preparing racemic and optically active 1-tert-butylamino-3-(2,5-dichloro-phenoxy)-2propanol - Google Patents

Process for preparing racemic and optically active 1-tert-butylamino-3-(2,5-dichloro-phenoxy)-2propanol

Info

Publication number
IL51574A
IL51574A IL51574A IL5157477A IL51574A IL 51574 A IL51574 A IL 51574A IL 51574 A IL51574 A IL 51574A IL 5157477 A IL5157477 A IL 5157477A IL 51574 A IL51574 A IL 51574A
Authority
IL
Israel
Prior art keywords
2propanol
butylamino
dichloro
phenoxy
tert
Prior art date
Application number
IL51574A
Other languages
English (en)
Other versions
IL51574A0 (en
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL51574A0 publication Critical patent/IL51574A0/xx
Publication of IL51574A publication Critical patent/IL51574A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL51574A 1976-03-02 1977-03-01 Process for preparing racemic and optically active 1-tert-butylamino-3-(2,5-dichloro-phenoxy)-2propanol IL51574A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76GO00001331A HU172137B (hu) 1976-03-02 1976-03-02 Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (2)

Publication Number Publication Date
IL51574A0 IL51574A0 (en) 1977-05-31
IL51574A true IL51574A (en) 1980-01-31

Family

ID=10996805

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51574A IL51574A (en) 1976-03-02 1977-03-01 Process for preparing racemic and optically active 1-tert-butylamino-3-(2,5-dichloro-phenoxy)-2propanol

Country Status (25)

Country Link
US (1) US4310549A (fi)
JP (1) JPS5923299B2 (fi)
AT (1) AT348507B (fi)
AU (1) AU508766B2 (fi)
BE (1) BE851938A (fi)
CA (1) CA1091254A (fi)
CH (1) CH627732A5 (fi)
CS (1) CS190340B2 (fi)
DD (1) DD128610A5 (fi)
DE (1) DE2709109C3 (fi)
DK (1) DK143554C (fi)
FI (1) FI65231C (fi)
FR (1) FR2342956A1 (fi)
GB (1) GB1573191A (fi)
HU (1) HU172137B (fi)
IL (1) IL51574A (fi)
IN (1) IN144243B (fi)
KE (1) KE3340A (fi)
MY (1) MY8500104A (fi)
NL (1) NL7702170A (fi)
NO (1) NO141989C (fi)
PL (1) PL103734B1 (fi)
SE (1) SE440647B (fi)
SU (1) SU648080A3 (fi)
YU (1) YU40813B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569692A5 (fi) 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
IL51574A0 (en) 1977-05-31
GB1573191A (en) 1980-08-20
HU172137B (hu) 1978-06-28
PL103734B1 (pl) 1979-07-31
ATA134177A (de) 1978-07-15
DK143554B (da) 1981-09-07
FI65231C (fi) 1984-04-10
YU40813B (en) 1986-06-30
AU508766B2 (en) 1980-04-03
FI770651A (fi) 1977-09-03
SE7702251L (sv) 1977-09-03
NO770688L (no) 1977-09-05
NO141989C (no) 1980-06-11
CA1091254A (en) 1980-12-09
DE2709109A1 (de) 1977-09-15
NO141989B (no) 1980-03-03
US4310549A (en) 1982-01-12
AT348507B (de) 1979-02-26
IN144243B (fi) 1978-04-15
YU54977A (en) 1982-10-31
DD128610A5 (de) 1977-11-30
MY8500104A (en) 1985-12-31
FI65231B (fi) 1983-12-30
KE3340A (en) 1983-11-25
DK143554C (da) 1982-03-08
FR2342956B1 (fi) 1982-11-26
CH627732A5 (de) 1982-01-29
FR2342956A1 (fr) 1977-09-30
CS190340B2 (en) 1979-05-31
SU648080A3 (ru) 1979-02-15
DE2709109B2 (de) 1980-01-17
DK88577A (da) 1977-09-03
JPS52122328A (en) 1977-10-14
JPS5923299B2 (ja) 1984-06-01
DE2709109C3 (de) 1980-09-18
AU2279577A (en) 1978-09-07
SE440647B (sv) 1985-08-12
BE851938A (fr) 1977-09-01
NL7702170A (nl) 1977-09-06

Similar Documents

Publication Publication Date Title
PH19006A (en) Process for the preparation of new optically active 1,4-dihydropyridine
YU40688B (en) Process for obtaining 5'-deoxy-5-fluoro-citidine and 5'-deoxy-5-fluoruridine, respectively
YU43523B (en) Process for obtaining optically active substituted azabicyclohexanes
HU173105B (hu) Sposob poluchenija 1-nitro-9-dialkilamino-izoalkilamino-akridinov i ikh solej
CS191321B2 (en) Process for preparing optically active 11-deoxy-16-aryloxy-omega-tetranorprostaglandines
CS192484B2 (en) Method of preparing optically active or racemic omega-nor-aromatic 13,14-dehydroprostaglandins
PT66743B (en) Process for preparing novel 2-oxy-5-isopropylidene-7-hydroxy-9-substituted-2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxocins
CS191891B2 (en) Process for preparing 5 amino 1,2,3-thiadiazole
JPS5328146A (en) Process for preparing optically active aresrolone
GB1513713A (en) Process for preparing 2-(2,2-dicyclohexylethyl)-piperidin
CS189001B2 (en) Process for preparing optically active 13,14-dehydro-11-deoxyprostaglandines
IL51574A (en) Process for preparing racemic and optically active 1-tert-butylamino-3-(2,5-dichloro-phenoxy)-2propanol
EG12752A (en) Process for preparing of 3,5,5 trimethylhexanoyl freeocene
CS193095B2 (en) Process for preparing 1,2-dihydroxycyclobuten 3,4-dione
HU174318B (hu) Sposob poluchenija 2,4-diamino-5-/3',4',5'-trimetoksi-benzil/-pirimidina
YU298677A (en) Process for preparing 3,4-dideoxy-kanamycin b
CS191296B2 (en) Process for preparing optically active or racemic fluorprostaglandine
JPS52139045A (en) Racemization process for optically active allethrolone
GB1520818A (en) Process for preparing 3,3-dimethylpent-4-enoic acid
YU42048B (en) Process for obtaining new pyrido (1,2-aopyrimidine derivatives, and optically active and pnysiologically tolerated salts thereof
CS184526B1 (en) 2'-halogen-2'-deoxy-5-fluoruridine,3',5-di-o-benzoyl-derivatives and process for preparing thereof
CS190348B2 (en) Process for preparing 2,5-dihydroxybenzensulphates
HU171551B (hu) Sposob poluchenija optichesko aktivnykh n-ciklopropilmetil-3-gidroksi-9-aza-morfinana i 3-gidroksi-9-aza-morfinana
CS182053B1 (en) Process for preparing 3,5-dinitro-o-toluamide
YU102776A (en) Process for preparing pyrido-1,4-diazepinone-3 and pyido-1,4-diazepine-2,3